Yutaka Niihara - 12 Jan 2023 Form 4 Insider Report for Emmaus Life Sciences, Inc. (EMMA)

Role
Chairman and CEO, Director, 10%+ Owner
Signature
Yutaka Niihara, M.D., M.P.H.
Issuer symbol
EMMA
Transactions as of
12 Jan 2023
Net transactions value
+$33,750,000
Form type
4
Filing time
17 Jan 2023, 12:59:20 UTC
Previous filing
01 Dec 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EMMA Warrants (right to buy) Award $33,750,000 +7,500,000 $4.50* 0 12 Jan 2023 Common Stock 7,500,000 $4.50 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.